Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference

SEATTLE--(BUSINESS WIRE)-- #VisusTx--Visus Therapeutics to Attend TD Cowen’s Health Care Conference. Topline Phase 3 data for best-in-class presbyopia candidate anticipated in 1H 2023.